Instructions for Arifon retard (Indapamide) 1,5 ml 30 pills
English product name
Arifon® Retard
Release Form
tab with controlled release, film sheath, 1.5 mg: 30 or 90 pcs.
Description Arifon retard
The controlled release tablets are coated with a film sheath, white in colour, round and double-convex.
1 tab.
indapamide 1.5 mg
Auxiliary substances: lactose monohydrate - 124.5 mg, hypromellose - 64 mg, magnesium stearate - 1 mg, povidon - 8.6 mg, silicon dioxide colloidal anhydrous - 0.4 mg.
The composition of the film shell: glycerol - 0.219 mg, hypromellose - 3.642 mg, macrogol 6000 - 0.219 mg, magnesium stearate - 0.219 mg, titanium dioxide - 0.701 mg.
30 pcs. - blister packs (1) - cardboard packs, with the control of the first opening (if necessary).
Packages for stationary:
30 pcs. - blister packs (3) - cardboard packs, with the control of the first opening (if necessary).
ATC codes
C03BA11 Indapamide
Clinical-pharmacological groups / Group affiliation
Diuretic
Active substance
indapamide
Pharmaco-therapeutic group Arifon retard
Diuretic agent
Storage Conditions
The drug should be stored in a place inaccessible to children at a temperature not higher than 30 ° C.
Best before date
The shelf life is 2 years. Do not apply after the expiry date indicated on the package.
Testimony Arifon retard
- arterial hypertension in adults.
Method of use, course and dosage Arifon retard
It is used in one tablet per day, preferably in the morning. The tablet should be swallowed whole, not chewing, washed with water.
Indapamide is contraindicated in patients with severe kidney failure (QC less than thirty ml/min). Thiazide and thiazide-like diuretics are only effective in patients with normal kidney function or minor kidney disorders.
The drug is contraindicated in patients with severe liver failure.
Pharmacological effect Arifon retard
Mechanism of Action Indapamide
Indapamide is a sulfonamide derivative containing an indole ring. In pharmacological properties, indapamide is close to the thiazide diuretics, which are associated with inhibition of the reverse absorption of sodium ions in the cortical segment of the nephron loop. Furthermore
- Nosology (ICD codes)
- I10
- Essential [primary] hypertension